Molecular mass: 169.968 g/mol PubChem compound: 131709156
The pertechnetate ion distributes in the body similarly to the iodide ion, but is not organified. In contrast to the iodide ion, the pertechnetate is released unchanged from the thyroid gland. Pertechnetate concentrates in the thyroid gland, salivary glands, gastric mucosa and choroid plexus. It is used in nuclear medicine in several nuclear scanning procedures.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
ATC code | Group title | Classification |
---|---|---|
V09FX01 | Technetium (99mTc) pertechnetate | V Various → V09 Diagnostic radiopharmaceuticals → V09F Thyroid → V09FX Various thyroid diagnostic radiopharmaceuticals |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Title | Information Source | Document Type | |
---|---|---|---|
RADIOGENIX SYSTEM Technetium tc 99m generator injection | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Technetium ⁹⁹ᵐTc pertechnetate is an active ingredient of these brands:
United States (US)
Austria (AT)
Estonia (EE)
France (FR)
Ireland (IE)
Lithuania (LT)
Malta (MT)Poland (PL)
Romania (RO)Singapore (SG)
Spain (ES)
Turkey (TR)United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.